Fingolimod - PDFSEARCH.IO - Document Search Engine

Fingolimod
Results: 83

#	Item
11	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Anatomy Aging-associated diseases Autoimmune diseases Tocilizumab Multiple sclerosis Scottish Medicines Consortium Rheumatoid arthritis Fingolimod Vemurafenib Health Medicine Immunosuppressants
12	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Multiple sclerosis Prostate cancer Abiraterone Scottish Medicines Consortium Fingolimod Hereditary angioedema Testosterone Prednisone Placebo Medicine Health Endocrine system
13	7.10 ALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Pharmacology Medicine Natalizumab Alemtuzumab Fingolimod Clinical trial Immunosuppressants Immunology Multiple sclerosis
14	Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Diols Fingolimod Natalizumab Alemtuzumab Immune system Immunosuppressants Immunology Multiple sclerosis
15	Microsoft Word - Sanofi- 5.1 alemtuzumabPSD final.docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-04-22 23:39:46 Immunosuppressants Medicine Cytokines Autoimmune diseases Treatment of multiple sclerosis Glatiramer acetate Natalizumab Fingolimod Interferon beta-1a Immunology Immune system Multiple sclerosis
16	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:14 Multiple sclerosis Immune system Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
17	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI WP5 Report 1:b:iv Benefit-Risk Wave 1 case study report: NATALIZUMAB Risk benefit case study with a focus on testing methodology. Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Multiple sclerosis Health Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
18	Submission on Authority Required Medicines for the Post-market Review of Authority Required PBS Listings ® Gilenya (fingolimod) October 2014 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-02 18:33:43 Pharmaceutical sciences Fingolimod Multiple sclerosis Medical prescription Patient safety Off-label use Clinical trial Bupropion Pharmacovigilance Medicine Pharmacology Health
19	Scottish Medicines Consortium Minutes of the SMC Meeting held on Tuesday 05 August 2014 The Lighthouse, 11 Mitchell Lane, Glasgow G1 3NU Present: Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English NHS Scotland Scottish Medicines Consortium National Institute for Health and Clinical Excellence Fingolimod Department of Health United Kingdom Clinical pharmacology Health Medicine
20	Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Healthcare in Australia Pharmaceuticals policy Pharmaceutical Benefits Scheme Quality use of medicines Drug safety Fingolimod Cetuximab Pharmacovigilance Antipsychotic Medicine Pharmacology Health

UPDATE